What is the added value of the waist-to-hip ratio on top of the BIOSTAT risk prediction model in patients with heart failure?

Abstract

I read with great interest the article by Streng et al. published in the European Journal of Heart Failure. I congratulate the authors for a solid study design and very exciting results. Streng et al. conducted a very valuable study where 1479 patients with waist and hip measurements from the BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT‐CHF) validation cohort were analysed. The authors found that there was a significant association between waist‐to‐hip ratio (WHR) and mortality in women with heart failure (HF)